Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs
US7569676B2 · kind B2 · utility
0Cited by
6References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 2005 |
| Grant date | Aug 4, 2009 |
| Priority date | — |
| Expiry date | Dec 1, 2025 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/809
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention comprises novel analogs of ecstasy-class compounds and novel ecstasy-class immunogens leashed out of, i.e., derived from, the methylenedioxy position. The invention also comprises unique monoclonal antibodies generated using MDO-leashed MDMA immunogens as well as unique conjugates and tracers. These antibodies, conjugates, and tracers are useful in immunoassays for the detection of ecstasy-class compounds in biological fluids.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.